Search for lead structures to develop new allosteric modulators of muscarinic receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 2, 1996, Pages 926-933

  Tränkle, Christian ^a   Kostenis, Evi ^a,b   Burgmer, Ulrike ^a   Mohr, Klaus ^a  

^a UNIVERSITY OF BONN   (Germany)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCURONIUM; BIS(PYRIDINIUM OXIME) DERIVATIVE; GALLAMINE; HEXAMETHONIUM; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OBIDOXIME; TACRINE;

ALLOSTERISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DOSE TIME EFFECT RELATION; DRUG POTENCY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR GENE; STRUCTURE ANALYSIS; SWINE;

ALCURONIUM; ALLOSTERIC REGULATION; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GALLAMINE TRIETHIODIDE; N-METHYLSCOPOLAMINE; RECEPTORS, MUSCARINIC; SCOPOLAMINE DERIVATIVES; STRUCTURE-ACTIVITY RELATIONSHIP; SWINE;

EID: 0030433044     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. BEJEUHR, G., BLASCHKE, G., HOLZGRABE, U., MOHR, K., SÜRIG, U. AND TERFLOTH, G.: A stable and highly potent hexamethonium derivative which modulates muscarinic receptors allosterically in guinea-pig hearts. J. Pharm. Pharmacol. 46: 108-112, 1994.
2. BEJEUHR, G., HOLZGRABE, U., MOHR, K., SÜRIG, U. AND VON PETERSENN, A.: Molecular modelling and synthesis of potent stabilizers of antagonist binding to M-cholinoceptors. Pharm. Pharmacol. Lett. 2: 100-103, 1992.
3. BIRDSALL, N. J. M., HULME, E. C., KROEMER, W. AND STOCKTON, J. M.: A second drug-binding site on muscarinic receptors. Fed. Proc. 46: 2525-2527, 1987.
4. BOTERO CID, H. B., HOLZGRABE, U., KOSTENIS, E., MOHR, M. AND TRÄNKLE, C.: Search for the pharmacophore of bispyridinium-type allosteric modulators of muscarinic receptors, J. Med. Chem. 37: 1439-1445, 1994.
5. 2-receptors. Naunyn-Schmiedebergs Arch. Pharmacol. 353: suppl., R83, 1996.
6. CHOO, L. K. AND MITCHELSON, F.: Characterisation of the antimuscarinic effect of heptane-1,7-bis-(dimethyl-3′-phthalimidopropyl ammonium bromide). Eur. J. Pharmacol. 162: 429-435, 1989.
7. 2 muscarine receptors. Mol. Pharmacol. 46: 105-114, 1994.
8. CLARK, A. L. AND MITCHELSON, F.: The inhibitory effect of gallamine on muscarinic receptors. Br. J. Pharmacol. 58: 323-331, 1976.
9. 5 muscarinic receptor subtypes. Biochem. Pharmacol. 42: 1927-1932, 1991.
10. ELLIS, J. AND SEIDENBERG, M.: Two allosteric modulators interact at a common site on cardiac muscarinic receptors. Mol. Pharmacol. 42: 638-641, 1992.
11. ELLIS, J., SEIDENBERG, M. AND BRANN, M. R.: Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions. Mol. Pharmacol. 44: 583-588, 1993.
12. GERRY, R. H., RAUCH, B., COLVIN, R. A., ADLER, P. A. N. AND MESSINO, F. C.: Verapamil interaction with the muscarinic receptor: Stereoselectivity at two sites. Biochem. Pharmacol. 36: 2951-2956, 1987.
13. GIRALDO, E., MICHELETTI, R., MONTAGNA, E., GIACHETTI, A., VIGANO, M. A., LADINSKY, M. AND MELCHIORRE, C.: Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine. J. Pharmacol. Exp. Ther. 244: 1016-1020, 1988.
14. HOLZGRABE, U. AND HOPFINGER, A. J.: Conformational analysis, molecular shape comparison, and pharmacophore identification of different allosteric modulators of muscarinic receptors. J. Chem. Inf. Comput. Sci., in press, 1996.
15. HOLZGRABE, U., WAGNER, M. AND GASTEIGER, J.: Comparison of structurally different allosteric modulators of muscarinic receptors by self-organizing neural networks. J. Mol. Graphics, in press, 1996.
16. 5 muscarinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 274: 1077-1083, 1995.
17. 3H]-N-methylscopolamine binding in guinea pig myocardium by an antidote against organophosphate intoxication. Pharmacol. Toxicol. 63: 163-168, 1988.
18. KORDS, H., LÜLLMANN, H., OHNESORGE, F. K. AND WASSERMANN, O.: Action of atropine and some hexane-1,6-bis-ammonium derivatives upon the toxicity of DFP in mice. Eur. J. Pharmacol. 3: 341-346, 1968.
19. KOSTENIS, E., BOTERO CID, H. M., HOLZGRABE, U. AND MOHR, K.: Evidence for a multiple binding mode of bispyridinium-type allosteric modulators of muscarinic receptors. Eur. J. Pharmacol., in press, 1996.
20. 2-receptors of derivatives of the alkane-bis-ammonium compound W84: Comparison with bispyridinium-type allosteric modulators. Eur. J. Med. Chem. 29: 947-953, 1994.
21. KOSTENIS, E. AND MOHR, K.: Two-point kinetic experiments to quantify allosteric effects on radioligand dissociation. Trends Pharmacol. Sci. 17: 280-283, 1996.
22. LAZARENO, S. AND BIRDSALL, N. J. M.: Detection and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: Interaction of strychnine and acetylcholine at muscarinic receptors. Mol. Pharmacol. 48: 362-378, 1995.
23. LEE, N. H. AND EL-FAKAHANY, E. E.: Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors: Identification of three main types of gallamine-muscarinic receptor interaction. J. Pharmacol. Exp. Ther. 246: 829-838, 1988.
24. LEE, N. H. AND EL-FAKAHANY, E. E.: Allosteric antagonists of the muscarinic acetylcholine receptor. Biochem. Pharmacol. 42: 199-205, 1991a.
25. 3 muscarinic receptor subtypes. J. Pharmacol. Exp Ther. 256: 468-479, 1991b.
26. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
27. LÜLLMANN, H., OHNESORGE, F. K., SCHAUWECKER, G. C. AND WASSERMANN, O.: Inhibition of the actions of carbachol and DFP on guinea pig isolated atria by alkane-bis-ammonium compounds. Eur. J. Pharmacol. 6: 241-247, 1969.
28. MAAß, A., KOSTENIS, E. AND MOHR, K.: Potentiation by alcuronium of the antimuscarinic effect of N-methylscopolamine in guinea pig left atria. Eur. J. Pharmacol. 272: 103-106, 1994.
29. MAAß, A. AND MOHR, K.: Opposite effects of alcuronium on agonist and antagonist binding to muscarinic receptors. Eur. J. Pharmacol., 305: 231-234, 1996.
30. MITCHELSON, F.: Antimuscarinic action of an alkane-bis-ammonium compound alone and in combination with (+)-benzetimide. Eur. J. Pharmacol. 33: 237-245, 1975.
31. 2-receptors. Life Sci. 52: 564, 1993.
32. 3H]NMS-binding to cardiac muscarinic receptors from guinea pig, rat, and pig. Pharmacol. Toxicol. 70: 198-200, 1992.
33. 1-receptors in rat cerebral cortex. Pharmacol. Toxicol. 75: 391-394, 1994.
34. NEDOMA, J., TUČEK, S., DANILOV, A. F. AND SHELKOVNIKOV, S. A.: Stabilization of antagonist binding to cardiac muscarinic acetylcholine receptors by gallamine and other neuromuscular blocking agents. J. Pharmacol. Exp. Ther. 236: 219-223, 1986.
35. 1 muscarinic receptors. Mol. Pharmacol. 35: 652-660, 1989.
36. PROŠKA, J. AND TUČEK, S.: Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors. Mol. Pharmacol. 45: 709-717, 1994.
37. PROŠKA, J. AND TUČEK, S.: Competition between positive and negative allosteric effectors on muscarinic receptors. Mol. Pharmacol. 48: 696-702, 1995.
38. STASCHEN, C. M.: The allosteric effect of W84 on muscarinic receptors is weakly temperature dependent. Naunyn-Schmiedebergs Arch. Pharmacol. 343: suppl., R91, 1991.
39. STOCKTON, J. M., BIRDSALL, N. J. M., BURGEN, A. S. V. AND HULME, E. C.: Modification of the binding properties of muscarinic receptors by gallamine. Mol. Pharmacol. 23: 551-557, 1983.
40. 2-cholmoceptors. Naunyn-Schmiedebergs Arch. Pharmacol. 349: suppl., R76, 1994.
41. TUČEK, S., MUSÍLKOVÁ, J., NEDOMA, J., PROŠKA, J., SHELKOVNIKOV, S. AND VORLÍČEK, J.: Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors. Mol. Pharmacol. 38: 674-680, 1990.
42. TUČEK, S. AND PROŠKA, J.: Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 16: 205-212, 1995.
43. WAELBROECK, M.: Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors. Mol. Pharmacol. 46: 685-692, 1994.
44. 4 muscarinic receptor subtypes. Br. J. Pharmacol. 105: 97-102, 1992.
45. WAELBROECK, M., DE NEEF, P., ROBBERECHT, P. AND CHRISTOPHE, J.: Inhibitory effects of quinidine on rat heart muscarinic receptors. Life Sci. 35: 1069-1076, 1984a.
46. WAELBROECK, M., ROBBERECHT, P., DE NEEF, P. AND CHRISTOPHE, J.: Effects of verapamil on the binding properties of rat heart muscarinic receptors: Evidence for an allosteric site. Biochem. Biophys. Res. Commun. 121: 340-345, 1984b.
47. WAELBROECK, M., ROBBERECHT, P., DE NEEF, P. AND CHRISTOPHE, J.: Effects of d-tubocurarine on rat cardiac muscarinic receptors: A comparison with gallamine. J. Recept. Res. 8: 787-808, 1988.
48. 2 receptors by heparin due to receptor uncoupling. Eur. J. Pharmacol. 296: 113-118, 1996.
49. WASSERMANN, O.: Untersuchungen zur Pharmakokinetik bis-quartärer Substanzen in vivo und in vitro. Ph.D. thesis, University of Kiel, Germany, 1970.